Ivan Dimov Net Worth (Estimated)
Founder at Lucira Health · YC W15
Quick answer
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026.
Ivan Dimov is Founder at Lucira Health (YC W15). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Public
- Background: Bulgarian
- Education: PhD in Applied Biophysics from Dublin City University; Bachelor's and Master's degrees in Electronics, Telecommunications, and Computer Science from Universidad Técnica Federico Santa María, Chile.
- Region: United States of America
- Industries: Healthcare, Diagnostics
- Team size: 43
- Website: https://www.lucirahealth.com/
Who is Ivan Dimov?
Ivan Dimov is a co-founder of Lucira Health, a molecular diagnostics company, and currently serves as the CEO and co-founder of Orca Bio, which develops high-precision cell therapies.
Highlights:
- Co-founder of Lucira Health (YC W15 batch)
- Co-founder and CEO of Orca Bio
- Siebel Fellow and Visiting Instructor at Stanford University
Background
Ivan Dimov was born in Bulgaria. Heritage/background labels may be inferred and are not verified identity documents.
About Lucira Health
Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in...
Model inputs
- Stage: series-b
- Valuation tier: fallback-public
- Funding input: reported raise $15.0M
- Valuation note: Replace leftover unsourced $13M. Lock the published $15M Series B. Do not invent IPO proceeds as a private raise.
- Research as-of: 2026-09-14
- Funding source: https://www.biospace.com/lucira-health-inc-completes-series-b-financing
FAQ: Ivan Dimov net worth and Lucira Health valuation
What is Ivan Dimov's net worth?
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.
Ivan Dimov net worth
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026. This Ivan Dimov net worth figure is estimated paper wealth, not a verified statement of assets.
How much is Ivan Dimov worth?
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026. How much Ivan Dimov is worth here means estimated paper wealth from public company and role data — not financial advice.
How rich is Ivan Dimov?
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026. “How rich is Ivan Dimov” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.
Ivan Dimov fortune
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026. This Ivan Dimov fortune figure is estimated paper wealth only, not a verified statement of assets.
Ivan Dimov equity value
Ivan Dimov's estimated net worth / paper wealth is $37.5M (range $26.2M–$56.2M) as of 2026. Ivan Dimov equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.
What is Lucira Health valuation?
Lucira Health's estimated valuation on Entrepreneurial Check is $2.0B. Independent model output, not a verified appraisal or official mark.
What is Lucira Health post-money valuation?
Lucira Health's estimated valuation on Entrepreneurial Check is $2.0B. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.
What is Lucira Health funding?
Lucira Health funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Lucira Health raised is not a complete cap table — figures are estimates only.
How much did Lucira Health raise?
How much Lucira Health raised, when disclosed, informs the estimated Lucira Health valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.
How much money did Lucira Health raise?
How much money Lucira Health raised, when a public figure is available, is a model input for the estimated Lucira Health valuation on this profile. Estimates only — not a complete cap table.
What is Lucira Health series funding?
Lucira Health series funding, when a public raise is disclosed, informs the estimated Lucira Health valuation here. Not a complete financing history.
What company is Ivan Dimov building?
Ivan Dimov is Founder at Lucira Health, a Y Combinator-backed startup (batch W15).
What does Lucira Health do?
Lucira Health — Next generation infectious disease test kits
What YC batch is Ivan Dimov from?
Ivan Dimov is associated with Y Combinator batch W15.
Where did Ivan Dimov go to school?
Public profiles associate Ivan Dimov with PhD in Applied Biophysics from Dublin City University; Bachelor's and Master's degrees in Electronics, Telecommunications, and Computer Science from Universidad Técnica Federico Santa María, Chile..
What other companies is Ivan Dimov connected to?
Public associations for Ivan Dimov include Lucira Health, Stanford University, Blobcode Technologies Ltda., UC Berkeley.
Where is Ivan Dimov based?
Public directory data lists Ivan Dimov's region as United States of America.
What industry is Ivan Dimov in?
Ivan Dimov is listed under Healthcare, Diagnostics.
How big is Lucira Health?
Public data lists Lucira Health's team size as 43.
What is Lucira Health's status?
Lucira Health is listed as Public in public company data.
What is Ivan Dimov's background?
Publicly described labels for Ivan Dimov: Bulgarian.
What else is notable about Ivan Dimov?
Co-founder and CEO of Orca Bio.
Is Entrepreneurial Check affiliated with Y Combinator?
No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.